Page last updated: 2024-08-24

lathosterol and Dyslipidemia

lathosterol has been researched along with Dyslipidemia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Böhm, M; Cremers, B; Fliser, D; Friedrichs, S; Fuhrmann, A; Heine, GH; Kerksiek, A; Laufs, U; Lütjohann, D; Meyer, S; Scheller, B; Schött, HF; Schulze, PC; Seiler-Mußler, S; Sijbrands, E; Ulbricht, U; Weingärtner, O; Zawada, A1
Cofán, M; Forga, MT; Larrousse, M; Leyes, P; Martínez, E; Pérez-Heras, AM; Ros, E; Trabal, J1
Hattori, S; Hattori, Y1
Lupattelli, G; Mannarino, E; Mannarino, MR; Pirro, M; Roscini, AR; Schillaci, G; Siepi, D1
Athias, A; Beacco, M; Bouillet, B; Brindisi, MC; Cercueil, JP; Duvillard, L; Guiu, B; Hillon, P; Petit, JM; Rollot, F; Verges, B1

Other Studies

5 other study(ies) available for lathosterol and Dyslipidemia

ArticleYear
Low serum lathosterol levels associate with fatal cardiovascular disease and excess all-cause mortality: a prospective cohort study.
    Clinical research in cardiology : official journal of the German Cardiac Society, 2019, Volume: 108, Issue:12

    Topics: Aged; Biomarkers; Cardiovascular Diseases; Cause of Death; Cholesterol; Dyslipidemias; Female; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Time Factors

2019
Effects of ezetimibe on cholesterol metabolism in HIV-infected patients with protease inhibitor-associated dyslipidemia: a single-arm intervention trial.
    BMC infectious diseases, 2014, Sep-11, Volume: 14

    Topics: Adult; Aged; Anticholesteremic Agents; Azetidines; C-Reactive Protein; Cholesterol; Cholesterol, LDL; Dyslipidemias; Ezetimibe; Female; HIV Infections; Humans; Lipid Metabolism; Male; Middle Aged; Phytosterols; Protease Inhibitors

2014
Efficacy and safety of ezetimibe in patients undergoing hemodialysis.
    Endocrine journal, 2010, Volume: 57, Issue:11

    Topics: Aged; Anticholesteremic Agents; Azetidines; C-Reactive Protein; Cholesterol; Dyslipidemias; Ezetimibe; Female; Glycated Hemoglobin; Humans; Linear Models; Male; Middle Aged; Phytosterols; Renal Dialysis; Renal Insufficiency; Triglycerides

2010
Visceral fat positively correlates with cholesterol synthesis in dyslipidaemic patients.
    European journal of clinical investigation, 2012, Volume: 42, Issue:2

    Topics: Adult; Body Fat Distribution; Body Mass Index; Cholesterol; Chromatography, Gas; Dyslipidemias; Female; Humans; Intra-Abdominal Fat; Male; Mass Spectrometry; Middle Aged; Phytosterols; Sitosterols; Statistics as Topic; Ultrasonography; Waist Circumference

2012
Liver fat content is associated with an increase in cholesterol synthesis independent of statin therapy use in patients with type 2 diabetes.
    Atherosclerosis, 2012, Volume: 224, Issue:2

    Topics: Aged; Biomarkers; Cholesterol; Diabetes Mellitus, Type 2; Dyslipidemias; Fatty Liver; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Linear Models; Liver; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multivariate Analysis; Non-alcoholic Fatty Liver Disease; Phytosterols; Risk Factors; Sitosterols; Treatment Outcome

2012